These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25457350)
1. Disrupting the scaffold, an alternative approach to inhibiting FAK. Chen S; Haas M; Sun S Cell Cycle; 2014; 13(24):3794-5. PubMed ID: 25457350 [No Abstract] [Full Text] [Related]
2. A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells. Kurenova E; Ucar D; Liao J; Yemma M; Gogate P; Bshara W; Sunar U; Seshadri M; Hochwald SN; Cance WG Cell Cycle; 2014; 13(16):2542-53. PubMed ID: 25486195 [TBL] [Abstract][Full Text] [Related]
3. Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo. Kurenova EV; Hunt DL; He D; Magis AT; Ostrov DA; Cance WG J Med Chem; 2009 Aug; 52(15):4716-24. PubMed ID: 19610651 [TBL] [Abstract][Full Text] [Related]
4. Building skeletally diverse architectures on the Indoline Scaffold: the discovery of a chemical probe of focal adhesion kinase signaling networks. Prakesch M; Bijian K; Campagna-Slater V; Quevillon S; Joseph R; Wei CQ; Sesmilo E; Reayi A; Poondra RR; Barnes ML; Leek DM; Xu B; Lougheed C; Schapira M; Alaoui-Jamali M; Arya P Bioorg Med Chem; 2008 Nov; 16(21):9596-602. PubMed ID: 18835181 [TBL] [Abstract][Full Text] [Related]
5. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo. Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478 [TBL] [Abstract][Full Text] [Related]
6. Indigo naturalis and its component tryptanthrin exert anti-angiogenic effect by arresting cell cycle and inhibiting Akt and FAK signaling in human vascular endothelial cells. Chang HN; Huang ST; Yeh YC; Wang HS; Wang TH; Wu YH; Pang JH J Ethnopharmacol; 2015 Nov; 174():474-81. PubMed ID: 26341616 [TBL] [Abstract][Full Text] [Related]
7. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis. Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414 [TBL] [Abstract][Full Text] [Related]
10. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Abu-Ghazaleh R; Kabir J; Jia H; Lobo M; Zachary I Biochem J; 2001 Nov; 360(Pt 1):255-64. PubMed ID: 11696015 [TBL] [Abstract][Full Text] [Related]
11. Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors. Moen I; Gebre M; Alonso-Camino V; Chen D; Epstein D; McDonald DM Clin Exp Metastasis; 2015 Dec; 32(8):799-817. PubMed ID: 26445848 [TBL] [Abstract][Full Text] [Related]
12. Priming Endothelial Cells With a Melanoma-Derived Extracellular Matrix Triggers the Activation of αvβ3/VEGFR2 Axis. Helal-Neto E; Brandão-Costa RM; Saldanha-Gama R; Ribeiro-Pereira C; Midlej V; Benchimol M; Morandi V; Barja-Fidalgo C J Cell Physiol; 2016 Nov; 231(11):2464-73. PubMed ID: 27420801 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Takahashi N; Seko Y; Noiri E; Tobe K; Kadowaki T; Sabe H; Yazaki Y Circ Res; 1999 May; 84(10):1194-202. PubMed ID: 10347094 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting focal adhesion kinase (FAK) blocks IL-4 induced VCAM-1 expression and eosinophil recruitment in vitro and in vivo. Aulakh GK; Petri B; Wojcik KM; Colarusso P; Lee JJ; Patel KD J Leukoc Biol; 2018 Jul; 104(1):147-158. PubMed ID: 29633338 [TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms. Bryant P; Zheng Q; Pumiglia K Mol Cell Biol; 2006 Jun; 26(11):4201-13. PubMed ID: 16705171 [TBL] [Abstract][Full Text] [Related]
16. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439 [TBL] [Abstract][Full Text] [Related]
18. FAK inhibition reduces metastasis of α4 integrin-expressing melanoma to lymph nodes by targeting lymphatic VCAM-1 expression. Jeong K; Murphy JM; Rodriguez YAR; Kim JS; Ahn EE; Lim SS Biochem Biophys Res Commun; 2019 Feb; 509(4):1034-1040. PubMed ID: 30660359 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway. Jiang WG; Ye L; Ji K; Frewer N; Ji J; Mason MD Int J Oncol; 2012 Nov; 41(5):1635-42. PubMed ID: 22971748 [TBL] [Abstract][Full Text] [Related]
20. Signalling pathway of isophorone diisocyanate-responsive interleukin-8 in airway smooth muscle cells. Kuo PL; Huang MS; Huang SK; Ni WC; Hung JY; Ko YC; Hung CH; Tsai YM; Duh TH; Hsu YL Eur Respir J; 2011 May; 37(5):1226-36. PubMed ID: 20817708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]